Furey Raymond J., EVP, GC, CCO, CS, reported a transaction classified as grant at RIGEL PHARMACEUTICALS INC involving 19717.000000 shares for an estimated $0.00. Reported holdings after the transaction were 41617.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
EVP, GC, CCO & Corp Sec
The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years fro…
This number has been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
Includes 500 shares acquired under the Issuer's stock purchase plan.
The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continuous service to the I…
0 other filings
0 recent txs